Xencor



Ebitda Veränderung Datum
AbbVie USD 6.92B 258M 2024-12
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Arrowhead Research USD 397.34M 553.52M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Cytokinetics USD -153331000 16.67M 2025-03
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
J&J USD 7.88B 1.76B 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Xencor USD 7.14M 64.97M 2024-12



Xencor - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.